MacroGenics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.

About MGNX

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases.

CEO

Scott E. Koenig

CEOScott E. Koenig

Employees

339

Employees339

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

2000

Founded2000

Employees

339

Employees339

MGNX Key Statistics

Market cap

134.31M

Market cap134.31M

Price-Earnings ratio

-1.41

Price-Earnings ratio-1.41

Dividend yield

—

Dividend yield—

Average volume

487.37K

Average volume487.37K

High today

$2.22

High today$2.22

Low today

$2.14

Low today$2.14

Open price

$2.21

Open price$2.21

Volume

63.72K

Volume63.72K

52 Week high

$19.54

52 Week high$19.54

52 Week low

$2.14

52 Week low$2.14

Analyst ratings

56%

of 9 ratings

Buy

44.4%

Hold

55.6%

Sell